The association between serum uric acid and features of metabolic disturbances in young adults. 2021

Sylwia Płaczkowska, and Lilla Pawlik-Sobecka, and Izabela Kokot, and Agnieszka Piwowar
Diagnostics Laboratory for Teaching and Research, Faculty of Pharmacy with the Division of Laboratory Diagnostics, Wroclaw Medical University, Wroclaw, Poland.

BACKGROUND The increase in the number of people affected by different metabolic disturbances, especially among young people, is alarming. It seems worthwhile to reappraise the usefulness of commonly used laboratory parameters potentially associated with metabolic and metabolically obese normal weight syndrome. Serum uric acid may be considered as an indicator and/or a predictor of metabolic disorders. We evaluated serum uric acid concentration in relation to metabolic syndrome, as well as metabolically obese normal weight features, and examined its usefulness in improving metabolic and metabolically obese normal weight syndrome diagnosis in young people. METHODS In 349 apparently healthy people, aged 18-31, features of metabolic and metabolically obese normal weight syndrome and serum uric acid concentration were examined under fasting conditions. RESULTS Prevalence of metabolic syndrome increased in uric acid quartiles, while the percentage of metabolically obese normal weight syndrome was at a similar level in all uric acid quartiles. A relationship between uric acid concentration and features of metabolic disorders in quartile and correlation analysis was revealed. Data mining techniques did not indicate the usefulness of uric acid for distinguishing people with metabolic syndrome from those with metabolically obese normal weight syndrome. CONCLUSIONS We confirmed that in young people an increase in uric acid levels is more closely related to metabolic syndrome features than insulin resistance. Serum uric acid concentration could not be recommended as an independent, strong marker of metabolic or metabolically obese normal weight syndrome occurrence in young people, but finding its elevated concentration should be an indicator for screening for other disturbances associated with metabolic syndrome.

UI MeSH Term Description Entries

Related Publications

Sylwia Płaczkowska, and Lilla Pawlik-Sobecka, and Izabela Kokot, and Agnieszka Piwowar
January 2020, The Journal of the Association of Physicians of India,
Sylwia Płaczkowska, and Lilla Pawlik-Sobecka, and Izabela Kokot, and Agnieszka Piwowar
May 2012, Journal of preventive medicine and public health = Yebang Uihakhoe chi,
Sylwia Płaczkowska, and Lilla Pawlik-Sobecka, and Izabela Kokot, and Agnieszka Piwowar
December 2019, Journal of Korean medical science,
Sylwia Płaczkowska, and Lilla Pawlik-Sobecka, and Izabela Kokot, and Agnieszka Piwowar
May 2020, Scientific reports,
Sylwia Płaczkowska, and Lilla Pawlik-Sobecka, and Izabela Kokot, and Agnieszka Piwowar
January 2015, Journal of diabetes and metabolic disorders,
Sylwia Płaczkowska, and Lilla Pawlik-Sobecka, and Izabela Kokot, and Agnieszka Piwowar
March 2017, Asia Pacific journal of clinical nutrition,
Sylwia Płaczkowska, and Lilla Pawlik-Sobecka, and Izabela Kokot, and Agnieszka Piwowar
August 2007, Journal of hypertension,
Sylwia Płaczkowska, and Lilla Pawlik-Sobecka, and Izabela Kokot, and Agnieszka Piwowar
November 2006, Journal of the Chinese Medical Association : JCMA,
Sylwia Płaczkowska, and Lilla Pawlik-Sobecka, and Izabela Kokot, and Agnieszka Piwowar
September 2018, Korean journal of family medicine,
Sylwia Płaczkowska, and Lilla Pawlik-Sobecka, and Izabela Kokot, and Agnieszka Piwowar
January 2022, Frontiers in nutrition,
Copied contents to your clipboard!